World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
17277
World Ranking
3201
National Ranking
18

Angel Porgador publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Angel Porgador sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 222 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Angel Porgador D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Angel Porgador sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Angel Porgador is affiliated with Ben-Gurion University of the Negev in Israel. Their research intersects multiple disciplines within biomedical sciences, with a particular focus on medicine, biochemistry, genetics, molecular biology, immunology, and microbiology.

The scientist's work spans several subfields, including oncology, immunology, molecular biology, biomedical engineering, and pulmonary and respiratory medicine. Their research covers key topics such as CAR-T cell therapy, immunotherapy and immune responses, immune cell function and interaction, cancer immunotherapy and biomarkers, lung cancer treatments and mutations, monoclonal and polyclonal antibodies, and SARS-CoV-2 detection and testing.

Angel Porgador has contributed to several frequent publication venues, reflecting the breadth of their research interests. These venues include bioRxiv (Cold Spring Harbor Laboratory), International Journal of Molecular Sciences, Science Advances, Nano Letters, and Cancers.

Among the recent papers authored or co-authored by Angel Porgador are:

  • Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers, 2020, Science Advances
  • Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors, 2020, Nature Cancer
  • Efficient high throughput SARS-CoV-2 testing to detect asymptomatic carriers, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer, 2023, Science Advances
  • Mechanical Regulation of the Cytotoxic Activity of Natural Killer Cells, 2020, ACS Biomaterials Science & Engineering

Angel Porgador has frequently collaborated with several co-authors. Notable frequent collaborators include Mark Schvartzman, Guillaume Le Saux, Avishay Edri, Moshe Elkabets, and Yariv Greenshpan.

The scientist also has contributions to book publications. One documented title is "Immunity, Cancer and the Microenvironment: Resolving a 3-Way Standoff," published in 2023 by Frontiers Media.

Best Publications

  • Decidual NK cells regulate key developmental processes at the human fetal-maternal interface

    Jacob Hanna;Debra Goldman-Wohl;Yaron Hamani;Inbal Avraham

  • Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

    Ofer Mandelboim;Niva Lieberman;Marianna Lev;Lada Paul

  • Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody.

    Angel Porgador;Jonathan W Yewdell;Yuping Deng;Jack R Bennink

  • Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.

    Roi Gazit;Raizy Gruda;Moran Elboim;Tal I Arnon

  • Predominant Role for Directly Transfected Dendritic Cells in Antigen Presentation to CD8+ T Cells after Gene Gun Immunization

    Angel Porgador;Kari R. Irvine;Akiko Iwasaki;Brian H. Barber

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Recognition of viral hemagglutinins by NKp44 but not by NKp30

    Tal I. Arnon;Marina Lev;Gil Katz;Yehudit Chernobrov

  • Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

    Tal I Arnon;Hagit Achdout;Ofer Levi;Gal Markel

  • Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.

    Angel Porgador;Eli Gilboa

  • Induction of antitumor immunity using bone marrow-generated dendritic cells.

    Angel Porgador;David Snyder;Eli Gilboa

  • The mechanisms controlling the recognition of tumor and virus infected cells by NKp46

    Tal I. Arnon;Hagit Achdout;Hagit Achdout;Niva Lieberman;Niva Lieberman;Roi Gazit;Roi Gazit

  • Interleukin 6 Gene Transfection into Lewis Lung Carcinoma Tumor Cells Suppresses the Malignant Phenotype and Confers Immunotherapeutic Competence against Parental Metastatic Cells

    Angel Porgador;Esther Tzehoval;Anne Katz;Ezra Vadai

  • Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2

    Sonja Textor;Nathalie Fiegler;Annette Arnold;Angel Porgador

  • Cell type-specific DNA methylation patterns in the human breast

    Noga Bloushtain-Qimron;Noga Bloushtain-Qimron;Jun Yao;Eric L. Snyder;Michail Shipitsin

  • Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium

    Ramakrishna Vankayalapati;Ankita Garg;Angel Porgador;David E. Griffith

  • Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44

    Benyamin Rosental;Michael Brusilovsky;Uzi Hadad;Dafna Oz

  • Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor

    Ankita Garg;Peter F. Barnes;Angel Porgador;Sugata Roy

  • The activating receptor NKp46 is essential for the development of type 1 diabetes

    Chamutal Gur;Angel Porgador;Moran Elboim;Roi Gazit

  • The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained.

    Wherry Ej;Puorro Ka;Porgador A;Eisenlohr Lc

  • The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium

    Ramakrishna Vankayalapati;Benjamin Wizel;Stephen E. Weis;Hassan Safi

Frequent Co-Authors

Ofer Mandelboim
Ofer Mandelboim Hebrew University of Jerusalem
Jacob H. Hanna
Jacob H. Hanna Weizmann Institute of Science
Michael Feldman
Michael Feldman Weizmann Institute of Science
Ron N. Apte
Ron N. Apte Ben-Gurion University of the Negev
Adelheid Cerwenka
Adelheid Cerwenka Heidelberg University
Ron Dagan
Ron Dagan Ben-Gurion University of the Negev
Gal Markel
Gal Markel Tel Aviv University
Eli Gilboa
Eli Gilboa University of Miami
Raz Jelinek
Raz Jelinek Ben-Gurion University of the Negev
Michael Feldman
Michael Feldman University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding into allied healthcare fields can open diverse career opportunities. One such path is becoming a psychiatric mental health nurse practitioner. Many students explore the best psychiatric mental health nurse practitioner programs online to gain specialized skills and secure strong clinical placements.

Cost is often a major consideration. Prospective students seeking affordable options should consider the cheapest online pmhnp certificate programs. These programs provide accessible pathways to certification without compromising quality.

Financial outcomes are an important factor when selecting a degree. Understanding how much do dnp nurses make can help candidates evaluate the return on investment for advanced nursing degrees combined with immunology expertise.

For practicing nurses aiming to advance their clinical scope, the fnp to acnp bridge program online offers a flexible way to transition from Family Nurse Practitioner to Acute Care Nurse Practitioner, integrating immunology knowledge into critical care settings.

Best Scientists Citing Angel Porgador

Trending Scientists

Recently Published Articles